QMS Medical Allied Services Ltd
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
- Market Cap ₹ 166 Cr.
- Current Price ₹ 85.7
- High / Low ₹ 113 / 71.5
- Stock P/E 14.1
- Book Value ₹ 54.4
- Dividend Yield 0.58 %
- ROCE 16.6 %
- ROE 14.4 %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding has decreased over last quarter: -5.56%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|
| 122 | 156 | 173 | |
| 104 | 130 | 147 | |
| Operating Profit | 18 | 25 | 26 |
| OPM % | 15% | 16% | 15% |
| 0 | 2 | 2 | |
| Interest | 3 | 5 | 6 |
| Depreciation | 3 | 4 | 4 |
| Profit before tax | 12 | 19 | 18 |
| Tax % | 26% | 27% | |
| 9 | 14 | 14 | |
| EPS in Rs | 4.66 | 6.26 | 6.10 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -22% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|
| Equity Capital | 18 | 18 | 19 |
| Reserves | 61 | 72 | 86 |
| 35 | 60 | 58 | |
| 22 | 40 | 47 | |
| Total Liabilities | 135 | 190 | 210 |
| 24 | 53 | 55 | |
| CWIP | 2 | 3 | 0 |
| Investments | 2 | 3 | 1 |
| 108 | 131 | 154 | |
| Total Assets | 135 | 190 | 210 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | |
|---|---|---|
| 1 | 20 | |
| -3 | -45 | |
| 0 | 26 | |
| Net Cash Flow | -1 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Debtor Days | 124 | 101 |
| Inventory Days | 172 | 176 |
| Days Payable | 90 | 76 |
| Cash Conversion Cycle | 205 | 202 |
| Working Capital Days | 148 | 100 |
| ROCE % | 17% |
Documents
Announcements
-
Investor Presentation
20 February 2026 - Q3 revenue ₹37.3cr, Q3 PAT ₹3.2cr; 9MFY26 revenue ₹128.5cr, 9MFY26 PAT ₹9.9cr.
-
Acquisition
19 February 2026 - Amendment: acquisition of Prometheus for Rs.78,00,000; completion by 30 Sept 2026 in tranches.
-
Monitoring Agency Report
14 February 2026 - CARE report on Rs.12.05 crore rights issue utilization for quarter ended Dec 31, 2025; Rs.0.01cr unutilized.
-
Statement of deviation(s) or variation(s) under Reg. 32
14 February 2026 - Rights issue proceeds Rs12.0483 crore; no deviation; quarter ended 31 Dec 2025.
-
Outcome of Board Meeting
14 February 2026 - Approved standalone and consolidated unaudited results for quarter and nine months ended Dec 31, 2025; limited review.
Annual reports
Concalls
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT
-
Aug 2025TranscriptPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.